MedPath

Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men

Not Applicable
Completed
Conditions
Body Composition
Muscle Strength
Lean Body Mass
Muscle Power
Interventions
Dietary Supplement: Effect of collagen peptides, in combination with resistance training, on body composition and muscle strength compared to placebo in untrained men
Registration Number
NCT06061315
Lead Sponsor
University of Southern Denmark
Brief Summary

The effect of resistance training with post-exercise Collagen peptides (CP) supplementation on lean body mass, maximal and explosive, isometric muscle strength as well as fat mass, resting metabolism, health parameters and compared to resistance training alone will be evaluated in a group of untrained overweight male (30-60 yrs) population in a randomized controlled trial (RCT).

Detailed Description

Participants will perform supervised resistance training involving (Leg press, pull down, chest press, back extension and abdominal crunches) 3 times a week for 12 weeks. Participants will consume either placebo or collagen peptides (in a double blinded study design) just following resistance training on training days (And approximately the same time of day on non-training days). Prior to, and following 12 weeks of exercise, participants will be tested in body composition, maximal and explosive, isometric muscle strength, resting metabolism, health parameters. Additionally, blood samples will be taken to ensure health and training eligibility and safety.

Participants are healthy untrained overweight males (30-60 yrs)

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
80
Inclusion Criteria
  • Male, between 30 and 60 years of age
  • Fat mass >25 % as measured by bioelectrical impedance analysis
  • Stable weight (±5 %) and eating behaviour within the last 3 months.
  • Signed informed consent
Exclusion Criteria
  • Regular physical activity >60 min / week
  • Stabile or progressive diseases/conditions (including medication) contraindicating or disabling participation in intensive exercise training and/or with potential to affect training adaptation beyond normal variation. For example:
  • Contraindications against physical stress corresponding guidelines of American College of Sports Medicine (ACSM)
  • Subjective symptoms during exercise (e.g., unusual physical exhaustion, dyspnoea, nausea)
  • Moderate to severe mobility limitation (i.e., due to rheumatic disease)
  • Diagnosis of cancer within the last 5 years
  • Diabetes mellitus I and II uncontrolled arterial hypertension (systolic blood pressure >155 for mmHg and/or diastolic blood pressure >94 mm Hg; mild hypertension under resting condition will be allowed but such participants will be recommended to consult their general practitioner).
  • Conditions contraindicating the supplementation protocol.
  • Contraindications against nutritional or ergogenic supplements
  • Allergy/aversion against animal protein
  • Liver or kidney diseases with a non-permission to ingest certain concentrations of protein.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Collagen peptide groupEffect of collagen peptides, in combination with resistance training, on body composition and muscle strength compared to placebo in untrained menThis group will consume 1 serving of Collagen peptides, which is produced and marketed ® by GELITA AG, Germany under the brand name BODYBALANC each day.
Primary Outcome Measures
NameTimeMethod
Lean body mass (kg)Pre (1week prior to intervention) and post (1 week following intervention. i.e 14weeks after inclusion) intervention - about 20 minutes for all dxa-measurements

Lean body mass measured by dual-energy X-ray absorptiometry (DXA)

Secondary Outcome Measures
NameTimeMethod
Resting energy expenditure (kcal pr. day)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - 15-25 minutes for all dxa-measurements

Resting energy expenditure measured with the ventilated hood and indirect calorimetry

1 Repetition maximum strength (kg)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 25 minutes for all 1RM measurements

1 repetition maximum strength in leg press, pull down and chest press

Maximal isometric knee extensor force (Nm)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 25 minutes for all isokinetic dynamometer measurements

Maximal isometric knee extensor force

Fat mass (kg)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 20 minutes for all dxa-measurements

Fat mass measured by dual-energy X-ray absorptiometry (DXA)

Knee extensor power (W)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 15 minutes

Unilateral knee extensor power (W)

Sit to standPre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 3 minutes

30 second sit to stand test

Rate of force development (Nm/sec)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 25 minutes for all isokinetic dynamometer measurements

Unilateral rate of force development from onset of force until 0-30, 0-50, 0-100, 0-200ms of the knee extensor

Full body bone mineral density (g/cm^2)Pre (1 week prior to intervention) and post (1 week following intervention. i.e 14 weeks after inclusion) intervention - about 20 minutes for all dxa-measurements

Full body bone mineral density (BMD) (obtained by DEXA)

Trial Locations

Locations (1)

The Department of Sports Science and Clinical Biomechanics at University of Southern Denmark

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath